X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Drug Development

Rising Pharmaceuticals Demand Drives Tablet Coatings Market

Content Team by Content Team
13th May 2023
in Drug Development, News

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

The worldwide tablet coatings sector generated $2.2 billion in 2021 and is projected to reach $4.1 billion by 2031, growing at a CAGR of 6.6% from 2022 to 2031. Key takeaways include:

Increasing pharmaceutical demand: Growing global demand for pharmaceuticals drives the tablet coatings market as more people seek medical treatments and prescription drugs.

Technological advancements: Advancements in coating technologies enhance tablet manufacturing efficiency, improving the safety and efficacy of the final product.

Nutraceutical demand: The popularity of natural health supplements increases the demand for coated nutraceuticals with improved taste and odor.

Regulatory compliance: Tough quality benchmarks and regulatory requirements ensure the safety and efficacy of tablet coatings.

The market for global tablet coatings can be segmented based on the following:

Product type: Film coatings, sugar coatings, enteric coatings, and other specialty coatings.

Material: Polymers, cellulose derivatives, and other materials.

End-user: Pharmaceutical industry, nutraceutical industry, and others.

Application: Extended-release coatings, taste masking coatings, and others.

Region: North America, Asia Pacific, Europe, Latin America, and Africa the Middle East.

Sales channel: Direct sales and distributor sales.

Coating thickness: Thin and thick coatings.

North America dominates the tablet coatings market with the highest revenue share, driven by a strong healthcare infrastructure, high purchasing power, and widespread adoption of coated tablets. However, the Asia-Pacific region is expected to have the fastest growth rate, with a projected CAGR of 7.2% from 2022 to 2031. Factors contributing to this growth include a growing geriatric population and increased awareness of delayed-release tablet coatings.

Two notable trends in the market are the rising demand for enteric coatings, which protect active ingredients in the stomach and enable targeted delivery to the small intestine, and the increasing use of nanotechnology to develop thin and uniform coatings for enhanced API protection. Furthermore, there is a growing emphasis on eco-friendly coatings using biodegradable materials, reflecting consumer concerns about the environmental impact of traditional coatings.

Recent developments in the tablet coatings market include the following:

Rising demand for enteric coatings: Enteric coatings protect active ingredients, ensuring targeted delivery to the small intestine. This is driving demand in the pharmaceutical and nutraceutical industries.

Increasing use of nanotechnology: Nanotechnology enables the development of ultra-thin, uniform coatings, improving API protection and creating more efficient products.

Development of eco-friendly coatings: Companies are creating biodegradable coatings to address environmental concerns and meet consumer demand for sustainability.

Previous Post

Connected Drug Delivery Devices To Revolutionize Healthcare

Next Post

European Medicines Agency Ends COVID-19 Prioritization Plan

Related Posts

idiopathic pulmonary fibrosis
Americas

US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

9th October 2025
Tissue Repair Drug
Clinical Trials

FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

7th October 2025
FastTrack Review
Americas

US FDA Launches Fast-Track Review Scheme for Generic Drugs

7th October 2025
AI Based Drug Discovery
Drug Development

Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

1st October 2025
API Manufacturing Facility
Americas

AbbVie Launches New API Manufacturing Facility in Illinois

1st October 2025
U.S. manufacturing
Americas

Amgen to Expand U.S. Manufacturing with $650M Investment

30th September 2025
Next Post

European Medicines Agency Ends COVID-19 Prioritization Plan

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In